
Brand Name | Status | Last Update |
|---|---|---|
| adult infuvite multiple vitamins | New Drug Application | 2025-08-18 |
| allevia | unapproved drug other | 2025-02-27 |
| anubis barcelona regul oil | OTC monograph final | 2023-09-01 |
| bacmin | unapproved drug other | 2014-05-02 |
| bal-care dha | unapproved drug other | 2012-05-01 |
| bal-care dha essential | unapproved drug other | 2012-05-01 |
| biovita | unapproved drug other | 2019-01-14 |
| c-nate dha | unapproved drug other | 2024-01-22 |
| centratex | unapproved drug other | 2024-01-31 |
| citranatal assure | unapproved drug other | 2024-01-08 |
Code | Description |
|---|---|
| J3411 | Injection, thiamine hcl, 100 mg |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | 4 | 6 | 4 | 24 | 37 |
| Septic shock | D012772 | — | A48.3 | 3 | 11 | 10 | 2 | 7 | 29 |
| Vitamin b 12 deficiency | D014806 | EFO_0000734 | E53.8 | 2 | 4 | 3 | 4 | 18 | 28 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | 2 | 9 | 6 | 3 | 8 | 25 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 2 | 7 | 12 | 1 | 5 | 24 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 5 | 8 | 2 | 8 | 23 |
| Thiamine deficiency | D013832 | — | E51 | 5 | 4 | — | 5 | 8 | 22 |
| Vitamin d deficiency | D014808 | EFO_0003762 | E55 | 2 | 2 | — | 3 | 13 | 20 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 3 | 4 | 3 | 11 | 20 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 3 | 4 | 2 | 10 | 19 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 5 | 12 | 7 | — | 1 | 21 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 4 | 4 | — | 6 | 16 |
| Recurrence | D012008 | — | — | 6 | 6 | 2 | — | 1 | 11 |
| Lung neoplasms | D008175 | — | C34.90 | 2 | 8 | 3 | — | — | 10 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 2 | 5 | 1 | — | — | 8 |
| Colorectal neoplasms | D015179 | — | — | 2 | 5 | 3 | — | — | 8 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | 2 | — | 2 | — | 4 | 8 |
| Depression | D003863 | — | F33.9 | 1 | 3 | 1 | — | 4 | 8 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | 1 | 2 | — | 5 | 7 |
| Avitaminosis | D001361 | EFO_0005878 | E56.9 | — | 2 | 4 | — | 3 | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 8 | 3 | — | — | 11 | 21 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | 5 | — | — | 1 | 7 |
| Lymphoma | D008223 | — | C85.9 | 5 | 6 | — | — | — | 7 |
| Multiple myeloma | D009101 | — | C90.0 | 3 | 4 | — | — | — | 6 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 3 | 2 | — | — | 2 | 5 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | 2 | — | — | — | 4 |
| Hodgkin disease | D006689 | — | C81 | 3 | 2 | — | — | — | 4 |
| Delirium | D003693 | — | R41.0 | — | 1 | — | — | 3 | 4 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | 1 | — | — | 3 | 4 |
| Autism spectrum disorder | D000067877 | — | F84.0 | — | 2 | — | — | 2 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 2 | — | — | — | — | 2 |
| Sezary syndrome | D012751 | — | C84.1 | 2 | — | — | — | — | 2 |
| Mycosis fungoides | D009182 | — | C84.0 | 2 | — | — | — | — | 2 |
| T-cell lymphoma cutaneous | D016410 | — | C84.A | 2 | — | — | — | — | 2 |
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | 1 | 2 |
| Nutritional status | D009752 | — | — | 1 | — | — | — | 1 | 2 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | 1 | — | — | — | 1 | 2 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | 1 | — | — | — | 1 | 2 |
| Heart disease risk factors | D000082742 | — | — | 1 | — | — | — | 1 | 2 |
| Burns | D002056 | — | T30.0 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Iron deficiencies | D000090463 | — | E61.1 | — | — | — | — | 10 | 10 |
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | — | — | — | 4 | 4 |
| Metabolic bone diseases | D001851 | — | — | — | — | — | — | 3 | 3 |
| Constipation | D003248 | — | K59.0 | — | — | — | — | 3 | 3 |
| Frailty | D000073496 | — | R53.1 | — | — | — | — | 3 | 3 |
| Folic acid deficiency | D005494 | EFO_0001070 | E53.8 | — | — | — | — | 3 | 3 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 3 | 3 |
| Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | — | — | — | — | 3 | 3 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | — | — | — | — | 2 | 2 |
| Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | — | — | — | — | 2 | 2 |
| Drug common name | Thiamine |
| INN | thiamine |
| Description | Thiamine(1+) is a primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a primary alcohol and a vitamin B1. It is a conjugate base of a thiamine(2+). |
| Classification | Small molecule |
| Drug class | Vitamin |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1.[Cl-] |
| PDB | — |
| CAS-ID | 59-43-8 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1588 |
| ChEBI ID | 33283 |
| PubChem CID | 1130 |
| DrugBank | DBSALT002650 |
| UNII ID | X66NSO3N35 (ChemIDplus, GSRS) |






